To overcome resistance, several case reports observed the therapeutic efficacy of MET inhibitor combined with EGFR inhibitor in patients with lung cancer appearing MET amplification detected by ctDNA testing after resistance to EGFR inhibitor (71–73). This evidence concerns the gene EGFR and lung cancer.